Posts

Posted on

BREAKING ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Lizhi Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – LIZI

PR Newswire

NEW YORK, Feb. 5, 2021 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Lizhi Inc. (NASDAQ: LIZI) pursuant and/or traceable to Lizhi’s January 17, 2020 initial public offering (the “IPO” or the “Offering”) of the important March 22, 2021 lead plaintiff deadline in the securities class action first filed by the firm.

SO WHAT: If you purchased Lizhi securities pursuant to the IPO you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Lizhi class action, go to http://www.rosenlegal.com/cases-register-1986.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.  A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 22, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013 and has recovered hundreds of millions of dollars for investors.  In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. 

DETAILS OF THE CASE: The complaint alleges that the Registration Statement contained false and/or misleading statements and/or failed to disclose that: (1) at the time of the IPO, the coronavirus was already ravaging China, the home base, principal market, and significant hub for Lizhi, its employees, and its customers; (2) the complications associated with the coronavirus were already negatively affecting Lizhi’s business, as employees and customers contracted the virus, lost employment, or otherwise experienced difficulty in generating, publishing, and monetizing the content critical to Lizhi’s platform; (3) even prior to the IPO, Lizhi employees and customers complained of, and to, Lizhi, which harmed the Company’s reputation and financial condition and prospects; and (4) as a result, defendants’ public statements were materially false and/or misleading at all relevant times.

To join the Lizhi class action, go to http://www.rosenlegal.com/cases-register-1986.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.   

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/breaking-alert-rosen-a-top-ranked-law-firm-encourages-lizhi-inc-investors-with-losses-over-100k-to-secure-counsel-before-important-deadline-in-securities-class-action-first-filed-by-the-firm–lizi-301223380.html

SOURCE Rosen Law Firm, P.A.

Posted on

BREAKING NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Tyson Foods, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline – TSN

BREAKING NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Tyson Foods, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline – TSN

NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Tyson Foods, Inc. (NYSE: TSN) between March 13, 2020 and December 15, 2020, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 5, 2021.

SO WHAT: If you purchased Tyson securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Tyson class action, go to http://www.rosenlegal.com/cases-register-2022.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. If you wish to serve as lead plaintiff, you must move the Court no later than April 5, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Tyson knew, or should have known, that the highly contagious coronavirus was spreading throughout the globe; (2) Tyson did not in fact have sufficient safety protocols to protect its employees in its facilities; (3) as a result, Tyson employees contracted and spread the coronavirus within the facilities; (4) as a result of the foregoing, Tyson would face negative impact to its production, including complete shutdowns of certain facilities; (5) due to the failure to protect its employees, Tyson would suffer financial harm related to its lowered production; and (6) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Tyson class action, go to http://www.rosenlegal.com/cases-register-2022.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

www.rosenlegal.com

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo
Posted on

Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Restaurant Brands International Inc. (QSR)

RADNOR, Pa., Feb. 05, 2021 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against Restaurant Brands International Inc. (NYSE: QSR) (“Restaurant Brands”) on behalf of those who purchased or acquired Restaurant Brands common stock between April 29, 2019, and October 28, 2019, inclusive (the “Class Period”).


Investor Reminder: Investors who purchased or acquired Restaurant Brands common stock


during the Class Period may,



no later than February 19, 2021



, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail at

[email protected]; orclick https://www.ktmc.com/restaurant-brands-international-inc-securities-class-action?utm_source=PR&utm_medium=link&utm_campaign=restaurant_brands

Restaurant Brands is a Canadian corporation and headquartered in Toronto, Ontario, Canada. It is one of the world’s largest restaurant chains with over 27,000 Tim Hortons, Burger King, and Popeyes restaurants in more than 100 countries and U.S. territories. On April 24, 2018, Restaurant Brands announced a new strategy designed to improve performance within its Tim Hortons brand. Specifically, the “Winning Together Plan” would focus on three key pillars: restaurant experience; product excellence; and brand communications. Then, on March 20, 2019, Restaurant Brands announced “Tims Rewards” – a new loyalty program for Tim Hortons customers in Canada. Under the Tims Rewards program, customers would be eligible for a free hot brewed coffee, hot tea, or baked good after every seventh paid visit to a participating Tim Hortons restaurant. On April 10, 2019, Restaurant Brands announced that it was expanding the Tims Rewards program to include customers in the United States.

The Class Period commences on April 29, 2019, when Restaurant Brands filed its financial results for the first quarter ended March 31, 2019 with the SEC. Among other things, Restaurant Brands reported 0.5% system-wide year-over-year sales growth for Tim Hortons on system-wide sales of $1.547 billion. The complaint alleges that, throughout the Class Period, the defendants repeatedly touted the implementation and execution of Restaurant Brands’ Winning Together Plan and Tims Rewards loyalty program. On the heels of Restaurant Brands touting the benefits of these initiatives, the company completed two stock offerings on or about August 12, 2019, and September 5, 2019, collectively resulting in proceeds of approximately $3 billion to insiders.

However, on October 29, 2019, the truth about Restaurant Brands’ execution of its Winning Together Plan and Tims Rewards loyalty program was revealed when the company announced disappointing financial results for the third quarter ended September 30, 2019. Among other things, Restaurant Brands reported a 0.1% system-wide year-over-year sales decline for Tim Hortons—representing a 1.4% same-store sales decline—on system-wide sales of $1.774 billion. Following this news, the price of Restaurant Brands common stock declined $2.59 per share, or approximately 4%, from a close of $68.45 per share on October 25, 2019, to close at $64.86 per share on October 28, 2019.

The complaint alleges that, throughout the Class Period, the defendants misrepresented and/or failed to disclose that: (1) Restaurant Brands’ Winning Together Plan was failing to generate substantial, sustainable improvement within the Tim Hortons brand; (2) the Tims Rewards loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and (3) as a result, the defendants’ statements about Restaurant Brands’ business, operations, and prospects lacked a reasonable basis.

Restaurant Brands investors may, no later than February 19, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, or other counsel, or may choose to do nothing and remain an absent class member.  A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.  In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class.  Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. 

Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world.  The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). For more information about Kessler Topaz Meltzer & Check, please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500 (toll free)
(610) 667-7706
[email protected]



Posted on

Ellington Financial Declares Common Dividend and Announces Estimated Book Value Per Common Share as of January 31, 2021

Ellington Financial Declares Common Dividend and Announces Estimated Book Value Per Common Share as of January 31, 2021

OLD GREENWICH, Conn.–(BUSINESS WIRE)–
Ellington Financial Inc. (NYSE: EFC) (the “Company”) today announced that its Board of Directors has declared a monthly dividend of $0.10 per common share, payable on March 25, 2021 to stockholders of record as of February 26, 2021.

The Company also announced its estimated book value per common share of $18.05 as of January 31, 2021. This estimate includes the effect of the previously announced monthly dividend of $0.10 per common share, payable on February 25, 2021 to holders of record on January 29, 2021, with an ex-dividend date of January 28, 2021.

Cautionary Statements

Estimated book value per common share is subject to change upon completion of the Company’s month-end and quarter-end valuation procedures relating to its investment positions, and any such change could be material. There can be no assurance that the Company’s estimated book value per common share as of January 31, 2021 is indicative of what the Company’s results are likely to be for the three-month period ending March 31, 2021 or in future periods, and the Company undertakes no obligation to update or revise its estimated book value per common share prior to issuance of financial statements for such periods. The Company’s independent registered public accounting firm has not audited, reviewed, compiled or performed any procedures with respect to the Company’s estimated book value per common share.

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve numerous risks and uncertainties. The Company’s actual results may differ from its beliefs, expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements are not historical in nature and can be identified by words such as “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “continue,” “intend,” “should,” “would,” “could,” “goal,” “objective,” “will,” “may,” “seek” or similar expressions or their negative forms, or by references to strategy, plans, or intentions. Examples of forward-looking statements in this press release include statements regarding the Company’s book value per common share and its payment of dividends, among others. The Company’s results can fluctuate from month to month and from quarter to quarter depending on a variety of factors, some of which are beyond the Company’s control and/or are difficult to predict, including, without limitation, changes in interest rates and the market value of the Company’s securities, changes in mortgage default rates and prepayment rates, the Company’s ability to borrow to finance its assets, changes in government regulations affecting the Company’s business, the Company’s ability to maintain its exclusion from registration under the Investment Company Act of 1940, the Company’s ability to maintain its qualification as a real estate investment trust, or “REIT,” and other changes in market conditions and economic trends, including changes resulting from the economic effects related to the COVID-19 pandemic, and associated responses to the pandemic. Furthermore, forward-looking statements are subject to risks and uncertainties, including, among other things, those described under Item 1A of the Company’s Annual Report on Form 10-K filed on March 13, 2020 and Part II, Item 1A of the Company’s Quarterly Report on Form 10-Q filed on May 21, 2020, as amended, which can be accessed through the Company’s website at www.ellingtonfinancial.com or at the SEC’s website (www.sec.gov). Other risks, uncertainties, and factors that could cause actual results to differ materially from those projected may be described from time to time in reports the Company files with the SEC, including reports on Forms 10-Q, 10-K and 8-K. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

This release and the information contained herein do not constitute an offer of any securities or solicitation of an offer to purchase securities.

About Ellington Financial

Ellington Financial invests in a diverse array of financial assets, including residential and commercial mortgage loans, residential and commercial mortgage-backed securities, consumer loans and asset-backed securities backed by consumer loans, collateralized loan obligations, non-mortgage and mortgage-related derivatives, equity investments in loan origination companies, and other strategic investments. Ellington Financial is externally managed and advised by Ellington Financial Management LLC, an affiliate of Ellington Management Group, L.L.C.

Investors:

Ellington Financial Inc.

Investor Relations

(203) 409-3575

[email protected]

or

Media:

Amanda Klein or Kevin FitzGerald

Gasthalter & Co.

for Ellington Financial

(212) 257-4170

[email protected]

KEYWORDS: Connecticut United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo
Posted on

BREAKING ALERT: Rosen, TRUSTED INVESTOR COUNSEL, Encourages Penumbra, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline – PEN

PR Newswire

NEW YORK, Feb. 5, 2021 /PRNewswire/ —

WHY:   Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 and December 15, 2020, inclusive (the “Class Period”), of the important March 16, 2021 lead plaintiff deadline.

SO WHAT: If you purchased Penumbra securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Penumbra class action, go to http://www.rosenlegal.com/cases-register-2003.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 16, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013 and has recovered hundreds of millions of dollars for investors.  In 2019 alone the firm secured over $438 million for investors.  In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Jet 7 Xtra Flex had known design defects that made it unsafe for its normal use; (2) Penumbra did not adequately address the risk of Jet 7 Xtra Flex causing serious injury and deaths, which had in fact already occurred; (3) the Jet 7 Xtra Flex was likely to be recalled due to its safety issues; and (4) as a result, Penumbra’s public statements as set forth in the complaint were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Penumbra class action, go to http://www.rosenlegal.com/cases-register-2003.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/breaking-alert-rosen-trusted-investor-counsel-encourages-penumbra-inc-investors-with-large-losses-to-secure-counsel-before-important-deadline–pen-301223369.html

SOURCE Rosen Law Firm, P.A.

Posted on

Mining for Miracles Launches 2021 Campaign to Establish Cellular and Regenerative Medicine Centre (CRMC) at BC Children’s Hospital

The $3.385M initiative will be the first of its kind in Western Canada

PRINCE GEORGE, British Columbia, Feb. 05, 2021 (GLOBE NEWSWIRE) — Mining for Miracles, the BC mining industry’s long-standing fundraising campaign for BC Children’s Hospital Foundation, launched its 2021 campaign today in support of BC Children’s Hospital’s Cellular and Regenerative Medicine Centre (CRMC), the first of its kind in Western Canada. Premier John Horgan joined BC mining industry representatives at the Virtual BC Natural Resources Forum today to launch this year’s fundraising campaign.

“Mining for Miracles continues to demonstrate how the women and men working in the BC mining industry contribute to the strength and resilience of families and communities across our province,” said Premier Horgan. “Over the years their campaigns have raised over $33 million to support innovative health care initiatives at BC Children’s Hospital. This is just one of the many ways the resource industry makes our province stronger.”

In 2021, Mining for Miracles will add to funds raised in 2020 toward their commitment to establish the CRMC, a $3.385 million initiative. The CRMC will give clinicians at BC Children’s the tools to better understand the genetic cause of heart arrhythmias so they can provide the best possible care to children in BC. It will result in improved diagnoses, identification of optimal treatments, and potentially, cures—improving and saving the lives of children across the province and beyond. In the future, the CRMC may also be used to provide answers for the thousands of children living with other life-altering conditions, like diabetes, cancer, bowel disease, and epilepsy.

“Once established, the Cellular and Regenerative Medicine Centre will become an important resource for researchers across BC Children’s,” said Dr. Wyeth Wasserman, Executive Director, BC Children’s Hospital Research Institute. “We are looking forward to the tremendous advances that will result when we combine the expertise of BC Children’s researchers with this leading-edge technology and facilities.”

“Every year thousands of women and men across the mining industry come together to raise funds to support important child health initiatives in BC,” said Karla Mills, Co-Chair of Mining for Miracles and Vice President, Project Development at Teck.

“Through the incredible support of the mining community year after year, we are helping ensure kids across our province have access to world class health care,” added Steve Krause, Co-Chair of Mining for Miracles and President of Avisar Chartered Professional Accountants.

Why is establishing the CRMC so important?

  • Every year, about 50,000 Canadians, including children, will die suddenly because of a cardiac arrest.
  • Ten per cent of children with heart rhythm disorders are at high risk for sudden cardiac arrest – a condition where the heart suddenly and unexpectedly stops beating, and, if not treated within minutes is fatal.
  • There are 1,000 families followed by the BC inherited heart rhythm disorder program, a group of specialists in cardiology, as well as medical genetics that identify, screen and manage individuals in the province affected by inherited heart rhythm conditions that put them at risk of sudden cardiac arrest.
  • Health care is increasingly using genetics to identify why diseases occur. The CRMC will give clinicians at BC Children’s the tools to better understand the genetic cause of heart arrhythmias so they can provide the best possible care to children in BC.
  • Currently, to find the appropriate treatment options to prevent cardiac arrest, doctors must determine through trial and error which heart arrhythmia medication combination is the right one for each individual child.
  • With only ten drops of blood, researchers at the CRMC will be able to create a “disease in a dish” where they can generate and study a specific child’s beating heart cells.
  • By studying cells in a lab, researchers can determine if children are at high risk of sudden cardiac arrest and help determine the best treatment options.

How BC Children’s CRMC will transform pediatric cardiac care

  • The CRMC will be the first of its kind in Western Canada
  • The CRMC has the potential to prevent years of uncertainty and reduce potential risks and side effects of ineffective drug options. BC’s kids need the CRMC so that they can receive a more accurate diagnosis and tailored treatment options.
  • The future vision for the CRMC is to expand beyond childhood heart arrhythmias and apply this state of the art technology to ultimately improve care for children living with other conditions, such as diabetes, cancer, bowel disease, and epilepsy.
  • BC Children’s has the clinical and scientific expertise to be leaders in pediatric cellular and regenerative medicine, but they require infrastructure and equipment to do this.

About Mining for Miracles

Every year, volunteers from the mining community work together through Mining for Miracles to help improve the quality of health care for children in our province. Through its support of the construction of facilities, ground-breaking research and the acquisition of specialized medical equipment at the hospital, Mining for Miracles is helping to keep BC Children’s Hospital at the forefront of excellence in pediatric care. The success of Mining for Miracles in funding initiatives like the CRMC depends on the generosity of individuals and corporations throughout British Columbia. Donations can be made through employee and corporate fundraising initiatives, or through fundraising events such as the annual Mining for Miracles Pie Throw, taking place virtually in late May 2021. Visit www.miningformiracles.ca for more information and to donate.

About BC Children’s Hospital Foundation
BC Children’s Hospital is the only hospital in the province devoted exclusively to the care of children, and is one of the few pediatric medical centres in North America with a world-class acute care centre, research institute, mental health facility and rehabilitation centre all on a single campus. Leading experts at BC Children’s provide a specialized level of expertise, innovative therapies and kid-focused care that can’t be found anywhere else in the province, including for the sickest and most seriously injured. At BC Children’s Hospital Foundation, we have a vision that every child is healthy and able to fulfill their hopes and dreams. The generosity of donors fuels our ability to help conquer childhood illnesses and address the biggest health challenges that face kids today. Please follow us at @bcchf or visit bcchf.ca for more information.

CONTACT INFORMATION

  • For more information please contact:
Karla Mills
Mining for Miracles Co-Chair
604.699.4618		 Steve Krause
Mining for Miracles Co-Chair
604.513.5707		 Meghan McQuaid
BC Children’s Hospital Foundation
Philanthropy Officer
604.818.3818

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/eb674266-a4d3-4bc6-840b-7ec4b61ba376



Posted on

IRTC INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against iRhythm Technologies, Inc.

PR Newswire

NEW YORK, Feb. 5, 2021 /PRNewswire/ — Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) from August 4, 2020 and January 28, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934.

If you purchased iRhythm securities, and/or would like to discuss your legal rights and options please visit iRhythm Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

The complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose to investors that: (1) iRhythm’s business would suffer as a result of the CMS’ rulemaking; (2) reimbursement rates would in fact plummet; (3) a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in the Company’s business; and (4) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

The truth began to be revealed on December 1, 2020, when the CMS issued its final rule, which finalized the codes as anticipated, but did not finalize national pricing for certain products and services offered by iRhythm. Shares opened on December 2, 2020 at $183.00 each, down from the December 1, 2020, close of $240.64 per share.

Then on January 29, 2021, Medicare Administrative Contractor Novitas Solutions published actual reimbursement rates under the CMS’ 2021 Medicare Physician Fee Schedule.  A Baird analyst commented that these rates were “way lower than” the former codes, citing one example where iRhythm was previously reimbursed around $311, but was now receiving just $42.68.

On this news, the price of iRhythm common stock closed at $168.42, down approximately 33% from its January 28, 2021 close of $251.00.

If you wish to serve as lead plaintiff, you must move the Court no later than April 2, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased iRhythm securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/irhythmtechnologiesinc-irtc-shareholder-class-action-lawsuit-stock-fraud-359/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero

Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/irtc-investor-filing-deadline-bernstein-liebhard-llp-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-irhythm-technologies-inc-301223364.html

SOURCE Bernstein Liebhard LLP

Posted on

SMICY INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Semiconductor Manufacturing International Corporation Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by Firm – SMICY

PR Newswire

NEW YORK, Feb. 5, 2021 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Semiconductor Manufacturing International Corporation (OTC: SMICY) between April 23, 2020 and September 26, 2020, inclusive (the “Class Period”), of the important February 8, 2021 lead plaintiff deadline in the securities class action first filed by the firm.

SO WHAT: If you purchased SMIC securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the SMIC class action, go to http://www.rosenlegal.com/cases-register-1961.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 8, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. 

DETAILS OF THE CASE: The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) there was an “unacceptable risk” that equipment supplied to SMIC would be used for military purposes; (2) SMIC was foreseeably at risk of facing U.S. restrictions; (3) as a result of restrictions by the U.S. Department of Commerce, certain of SMIC’s suppliers would need “difficult-to-obtain” individual export licenses; and (4) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the SMIC class action, go to http://www.rosenlegal.com/cases-register-1961.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.   

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/smicy-investor-notice-rosen-a-leading-law-firm-encourages-semiconductor-manufacturing-international-corporation-investors-with-losses-over-100k-to-secure-counsel-before-important-deadline-in-securities-class-action-first-filed-301223365.html

SOURCE Rosen Law Firm, P.A.

Posted on

FINAL DEADLINER ALERT: ROSEN, A TRUSTED LAW FIRM, Encourages Kandi Technologies Group, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Tuesday Deadline – KNDI

PR Newswire

NEW YORK, Feb. 5, 2021 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kandi Technologies Group, Inc. (NASDAQ: KNDI) between March 15, 2019 and November 27, 2020, inclusive (the “Class Period”), of the important February 9, 2021 lead plaintiff deadline.

SO WHAT: If you purchased Kandi securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT:  To join the Kandi class action, go to http://www.rosenlegal.com/cases-register-1998.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.   A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 9, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources.  The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.   Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013 and has recovered hundreds of millions of dollars for investors.  In 2019 alone the firm secured over $438 million for investors.  In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar.  Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. 

DETAILS OF THE CASE: The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Kandi artificially inflated its reported revenues through undisclosed related party transactions, or otherwise had relationships with key customers that indicated those customers did not have an arms-length relationship with Kandi; (2) the majority of Kandi’s sales in the past year had been to undisclosed related parties and/or parties with such a close relationship and history with Kandi that it cast doubt on the arms-length nature of their relationship; (3) all the foregoing, once revealed, was foreseeably likely to cast doubt on the validity of Kandi’s reported revenues and, in turn, have a foreseeable negative impact on the Company’s reputation and valuation; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Kandi class action, go to http://www.rosenlegal.com/cases-register-1998.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.   

No Class Has Been Certified.  Until a class is certified, you are not represented by counsel unless you retain one.  You may select counsel of your choice.  You may also remain an absent class member and do nothing at this point.  An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/final-deadliner-alert-rosen-a-trusted-law-firm-encourages-kandi-technologies-group-inc-investors-with-losses-over-100k-to-secure-counsel-before-important-tuesday-deadline–kndi-301223363.html

SOURCE Rosen Law Firm, P.A.

Posted on

CareTrust REIT Sets Fourth Quarter Earnings Call for Thursday, February 11, 2021

SAN CLEMENTE, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) — CareTrust REIT, Inc. (NASDAQ:CTRE) announced today that it plans to release its fourth quarter and full year 2020 financial results after the U.S. markets close on Wednesday, February 10, 2021. Representatives of CareTrust REIT’s management team will host a conference call to discuss the results and other current matters the following day.

Conference Call

CareTrust REIT invites current and prospective investors to listen to the call on Thursday, February 11, 2021 at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time). The dial-in number is (844) 220-4972 (U.S./Canada) or (317) 973-4053 (International) and the conference ID number is 9935506.

To listen to the call online as a webcast, or to view any financial or other statistical information required by SEC Regulation G, please visit the Investors section of the CareTrust REIT website at http://investor.caretrustreit.com. A recording of the call will be available for replay via the website for approximately 30 days following the call. The Company’s press releases, Securities and Exchange Commission filings, public conference calls, webcasts and website frequently disclose information that may be material to investors and the marketplace, and the Company encourages investors and others interested in the Company to regularly monitor such outlets for important Company information.

About CareTrust REIT

CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States. More information about CareTrust REIT is available at www.caretrustreit.com.

Contact:

CareTrust REIT, Inc.
(949) 542-3130
[email protected]